INDSWFTLTD.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (14 May 2024 @ 05:44):

Ind-Swift Limited manufactures and sells pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India...

Stats
Today's Volume	19 895.00
Average Volume	253 623
Market Cap	1.15B
EPS	INR0 ( 2024-02-14 )
Last Dividend	INR0.400 ( 2011-09-21 )
Next Dividend	INR0 ( N/A )
P/E	3.86
ATR14	INR0 (0.00%)

Ind-Swift Limited Correlation

10 Most Positive Correlations
GUJRAFFIA.NS	0.898
SABTN.NS	0.881
ROLLT.NS	0.876
HYBRIDFIN.NS	0.876
MOREPENLAB.NS	0.874
TGBHOTELS.NS	0.874
21STCENMGM.NS	0.871
MAXIND.NS	0.869
CONFIPET.NS	0.865
NECLIFE.NS	0.865

10 Most Negative Correlations
JINDCOT.NS	-0.883
ISMTLTD.NS	-0.861
BLUESTARCO.NS	-0.852
RAJRILTD.NS	-0.844
KAYNES.NS	-0.838
GNA.NS	-0.834
ROTO.NS	-0.827
JINDALSAW.NS	-0.823
DFMFOODS.NS	-0.823
KPRMILL.NS	-0.823

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ind-Swift Limited Financials

Annual	2022
Revenue:	INR4.11B
Gross Profit:	INR1.93B (46.94 %)
EPS:	INR4.81

FY	2022
Revenue:	INR4.11B
Gross Profit:	INR1.93B (46.94 %)
EPS:	INR4.81

FY	2022
Revenue:	INR3.98B
Gross Profit:	INR1.62B (40.63 %)
EPS:	INR-3.70

FY	2021
Revenue:	INR3.56B
Gross Profit:	INR1.70B (47.61 %)
EPS:	INR-5.50

Financial Reports:

No articles found.

Ind-Swift Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Ind-Swift Limited Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0.656 - low (50.00%) | Divividend Growth Potential Score: 2.52 - No dividend growth expected in the near future

Information

First Dividend	INR0.400	2005-09-22
Last Dividend	INR0.400	2011-09-21
Next Dividend	INR0	N/A
Payout Date	2011-10-26
Next Payout Date	N/A
# dividends	7	--
Total Paid Out	INR2.80	--
Avg. Dividend % Per Year	0.00%	--
Score	1.05	--
Div. Sustainability Score	0.656
Div.Growth Potential Score	2.52
Div. Directional Score	1.585	--

Next Divdend (Est)
(2024-06-27)

INR0 Estimate 0.00 %

Dividend Stability

0.02 Very Bad

Dividend Score

1.05

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0	0.00%
2020	INR0	0.00%
2021	INR0	0.00%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TATAMOTORS.NS	Dividend Junior	2023-07-28	Sporadic	29	0.14%
NLCINDIA.NS	Dividend Knight	2023-09-18	Annually	25	3.45%
INDIANB.NS	Dividend Junior	2023-06-12	Annually	18	1.99%
CIGNITITEC.NS	Dividend Knight	2023-06-09	Annually	4	0.29%
SATIA.NS	Dividend Junior	2023-09-22	Annually	6	0.35%
MAGADSUGAR.NS	Dividend Junior	2023-07-13	Annually	7	1.78%
GLOBAL.NS	Dividend Knight	2023-08-23	Semi-Annually	8	2.63%
ASPINWALL.NS	Dividend Junior	2023-07-20	Annually	7	1.81%
TNPETRO.NS	Dividend Junior	2023-09-18	Sporadic	23	2.02%
PFC.NS	Dividend King	2023-06-16	Quarterly	18	7.12%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0630	1.500	8.74	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	-0.0420	1.500	-1.578	-2.37	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0.470	1.000	-0.937	-0.937	[3 - 30]
operatingCashFlowPerShareTTM	18.32	2.00	3.89	7.79	[0 - 30]
freeCashFlowPerShareTTM	17.03	2.00	1.487	2.97	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.377	1.000	7.06	7.06	[0.2 - 0.8]
operatingProfitMarginTTM	0.0625	1.000	-0.749	-0.749	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				0.656

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	3.94	1.000	9.70	0	[1 - 100]
returnOnEquityTTM	-0.0420	2.50	-1.014	-2.37	[0.1 - 1.5]
freeCashFlowPerShareTTM	17.03	2.00	4.32	2.97	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	18.32	2.00	3.89	7.79	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0705	1.500	-3.80	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.210	1.000	7.25	0	[0.1 - 0.5]
Total Score				2.52

Ind-Swift Limited

Ind-Swift Limited manufactures and sells pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India. It offers medicines for various therapeutic segments, such as ENT, dentistry, anti-infective, cardio-diabetic, and orthopedic therapies under the Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin, and Stemin Forte names; gynecology, pediatrics, dermatology, and GP under the Anin, Suprox, Cozy, Distone, and Oliade name; and antibiotic, anti-cold, nutraceuticals, anti-diarrheal, anti-malarial, anti-depressants, cardiology, diabetology, neurology, and oncology. The company also provides contract research and manufacturing services. It serves government dispensaries, doctors, and hospitals through retailers, stockists, and carrying and forwarding channels. The company exports its products to approximately 50 countries. Ind-Swift Limited was founded in 1983 and is based in Chandigarh, India.

Realtime updates for Ind-Swift Limited [INDSWFTLTD.NS]

Upcoming Earnings Alert

Ind-Swift Limited Dividend Information - Ex Dividend Junior

Dividend Commentary

Top 10 dividend Companies for NSE

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)